CLASS II Device recall · Reported 3 Jul 2019 · FDA Enforcement Report
RNeasy DSP FFPE Kit recalled by Qiagen Sciences
Qiagen Sciences is recalling RNeasy DSP FFPE Kit, distributed nationwide in the US. The recall was initiated on 6 May 2019 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1891-2019
- FDA event ID
- 82985
- Recalling firm
- Qiagen Sciences, Germantown, MD
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 6 May 2019
- FDA classified
- 27 Jun 2019
- Reported
- 3 Jul 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Other Reasons
- Device type
- Test Kits & Diagnostics
Timeline
| 6 May 2019 | Recall initiated by company | |
| 27 Jun 2019 | Classified by FDA | +52 days |
| 3 Jul 2019 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
The deparaffinization solution contains a contaminant, which leads to reduced lysis efficiency of the affected lot, resulting in significantly reduced yields and less sensitive downstream applications.
Product as listed by the FDA
RNeasy DSP FFPE Kit (48), REF 73604 - Product Usage: The RNeasy DSP FFPE Kit is a system intended for the purification of total RNA from formalin-fixed, paraffin embedded (FFPE) tissues. The product is intended to be used by professional users, such as technicians and physicians that are trained in molecular biological techniques. It deploys an optimized silica spin-column-based protocol, and includes enzymatic removal of residual DNA. The RNeasy DSP FFPE Kit is intended for in vitro diagnostic use.
Where it was distributed
US nationwide distribution in the states of MA, RI, AZ, NY, NC, IN, TX. The products were distributed to the following foreign countries: Germany, Great Britain, Italy, France, Sweden, and Switzerland.
Nationwide ArizonaIndianaMassachusettsNorth CarolinaNew YorkRhode IslandTexas
Questions about this recall
Why was it recalled?
The deparaffinization solution contains a contaminant, which leads to reduced lysis efficiency of the affected lot, resulting in significantly reduced yields and less sensitive downstream applications.
Which lots are affected?
LOT 163016105
Where was it sold?
US nationwide distribution in the states of MA, RI, AZ, NY, NC, IN, TX. The products were distributed to the following foreign countries: Germany, Great Britain, Italy, France, Sweden, and Switzerland.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Qiagen Sciences
All 23| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | QIAstat-Dx Respiratory Panel Plus Reference Number recalled | Qiagen Sciences | Device Malfunction | 12 states |
| Device | CLASS II | QIAcube Connect MDx - IVD Instrument designed to perform recalled | Qiagen Sciences | Potency & Assay | Nationwide |
| Device | CLASS II | EZ2 Connect MDx-IVD Designed to perform automated isolation recalled | Qiagen Sciences | Temperature Abuse | Nationwide |
| Device | CLASS II | QIAstat-Dx Respiratory Sars-CoV-2 Panel multiplexed nucleic recalled | Qiagen Sciences | Other | Nationwide |
| Device | CLASS II | QIAcube Connect MDx recalled by Qiagen Sciences | Qiagen Sciences | Other | 26 states |
Other Test Kits & Diagnostics recalls
All 2,675| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Nextseq 550Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | NovaSeq 6000Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | Liaison Plex Gram-Negative Blood Culture Assay recalled by Luminex | Luminex | Potency & Assay | Nationwide |
| Device | CLASS II | MiSeq Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | Techno-Path Multichem AE Unassayed Level recalled | Techno-path Manufacturing | Potency & Assay | Nationwide |